The size of the Latin America Thrombectomy Devices Market is valued at USD 0.15 billion in 2022. It is estimated to be growing at a CAGR of 6.93%, to reach USD 0.21 billion by 2027.
Thrombectomy Devices can be defined as the removal of thrombi by using surgical procedures in cases of emergency, which can result in blocked blood circulation. Thrombi are actually blood clots, but in general usage, it can refer to any material that blocks blood flow and can lead to health problems. It is usually the final resort because of blood flow to organs for a long time can lead to necrosis.
A few commonly used Thrombectomy Devices procedures are surgical embolectomy, aspiration embolectomy, and balloon embolectomy. In surgical embolectomy, a clot is removed by surgical incision into an artery. Aspiration embolectomy is the removal of thrombus by using suction instead of a balloon. It is regarded as an effective way of removing thrombi in limb arteries. A catheter is inserted into a blood vessel in a balloon embolectomy, which has an inflatable balloon at the tip. It is inflated after its insertion into a clot, and then the balloon is pulled out along with the clot. This procedure is risky since there is a chance of intimal lesions, giving rise to another thrombosis.
The driving factors of the Latin America Thrombectomy Devices market are the growing geriatric population, rising prevalence of cardiovascular diseases, growing sedentary lifestyle, increasing demand for minimally invasive procedures, and technological innovations in the medical field. Some of the restraints involved in this market are difficulty using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases.
This research report on the Latin America Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By End Users:
By Disease:
By Country:
The market is geographically about to pick up its pace as it is still in its nascent stages. Factors such as the rising geriatric population, increased incidence of a sedentary lifestyle, and technological innovations are expected to drive this market's growth in the region.
Key market participants dominating the Latin American Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region